Page last updated: 2024-10-28

lidocaine and Leishmaniasis, Visceral

lidocaine has been researched along with Leishmaniasis, Visceral in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baranwal, AK1
Mandal, RN1
Singh, R1
Singhi, SC1

Other Studies

1 other study available for lidocaine and Leishmaniasis, Visceral

ArticleYear
Sodium stibogluconate and polymorphic ventricular tachycardia.
    Indian journal of pediatrics, 2005, Volume: 72, Issue:3

    Topics: Anti-Arrhythmia Agents; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Electric Countershoc

2005